Nicotine for the treatment of Tourette's Syndrome

Pharmacology and Therapeutics

Volumn 74, Issue 1, 1997, Pages 21-25

  Sanberg, Paul R ^a,b   Silver, Archie A ^b   Shytle, R Doug ^a,b   Philipp, Mary Katherine ^b   Cahill, David W ^a   Fogelson, Harold M ^c   McConville, Brian J ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Neuropsychiatric disorders; Nicotine; Tics; Tourette's syndrome

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; NICOTINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG MECHANISM; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPULSIVENESS; MALE; MOLECULAR INTERACTION; NEUROPSYCHIATRY; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; VISUOMOTOR COORDINATION;

EID: 0030747590     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(96)00199-4     Document Type: Review

References (51)

1. Adler, L. E., Hoffer, L. D., Wiser, A. and Freedman, R. (1993) Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am. J. Psychiatry 150: 1856-1861.
2. Balfour, D. J. K. (1989) Influence of nicotine on the release of monoamines in the brain. Prog. Brain Res. 79: 165-172.
3. Benwell, M. E., Balfour, D. J. and Khadra, L. F. (1994) Studies on the influence of nicotine infusions on mesolimbic dopamine and locomotor responses. Clin. Invest. 72: 233-239.
4. Bruun, R. D. and Budman, C. L. (1996) Risperidone as a treatment for Tourette's syndrome. J. Clin. Psychiatry 57: 29-31.
5. Buccafusco, J. J. and Jackson, W. J. (1991) Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys. Neurobiol. Aging 12: 233-238.
6. Clarke, P. B. S., Hommer, D. W., Pert, A. and Skirboll, L. R. (1985) Electrophysiological actions of nicotine on substantia nigra single units. Br. J. Pharmacol. 85: 827-835.
7. Cohen, D. J., Riddle, M. A. and Leckman, J. F. (1992) Pharmacotherapy of Tourette's syndrome and associated disorders. Psychiatr. Clin. North Am. 15: 109-129.
8. Comings, D. E. and Comings, B. G. (1988) Tourette's syndrome and attention deficit disorder. In: Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment (Wiley Series In Child and Adolescent Mental Health), pp. 119-135, Cohen, D. J., Bruun, R. D. and Leckman, J. F. (eds.) John Wiley and Sons, New York.
9. Decker, M. W., Brioni, J. D., Bannon, A. W. and Arneric, S. P. (1995) Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. Life Sci. 56: 545-570.
10. Devor, E. J. and Isenberg, K. E. (1989) Nicotine and Tourette's syndrome. Lancet 2: 1046.
11. Dimitsopuluos, T. and Kurlan, R. (1993) Tourette's syndrome and nicotine withdrawal. J. Neuropsychiatry 5: 108-109.
12. Dursan, S. M., Reveley, M. A., Bord, R. and Stirton, F. (1994) Long lasting improvement of Tourette's syndrome with transdermal nicotine. Lancet 344: 1577.
13. Emerich, D. F., Norman, A. B. and Sanberg, P. R. (1991a) Nicotine potentiates the behavioral effects of haloperidol. Psychopharmacol. Bull. 27: 385-390.
14. Emerich, D. F., Zanol, M. D., Norman, A. B., McConvilie, B. J. and Sanberg, P. R. (1991b) Nicotine potentiates haloperidol-induced catalepsy and hyperactivity. Pharmacol. Biochem. Behav. 38: 875-880.
15. Erenberg, G., Cruse, R. P. and Rothner, A. D. (1987) The natural history of Tourette syndrome: a follow-up study. Ann. Neurol. 22: 383-385.
16. Fagerström, K. O., Pomerleau, O., Giordani, B. and Stelson, F. (1994) Nicotine may relieve symptoms of Parkinson's disease. Psychopharmacology 116: 117-119.
17. Hakan, R. L. and Ksir, C. K. (1991) Acute tolerance to the locomotor stimulant effects of nicotine in the rat. Psychopharmacology 104: 386-390.
18. Harris, D. and Silver, A. A. (1995) Tourette's syndrome and learning disorders. Learn. Disabil. 6: 1-7.
19. Henningfield, J. E. and Keenan, R. M. (1993) Nicotine delivery kinetics and abuse liability. J. Consult. Clin. Psychol. 61: 743-750.
20. Hulihan-Giblin, B. A., Lumpkin, M. D. and Kellar, K. J. (1989) Effects of chronic administration of nicotine on prolactin release in the rat: inactivation of prolactin response by repeated injections of nicotine. J. Pharmacol. Exp. Ther. 252: 21-25.
21. Jarvik, M. E. (1991) Beneficial effects of nicotine. Br. J. Addict. 86: 571-575.
22. Leckman, J. F., Riddle, M. A., Hardin, M. T., Ort, S. I., Swartz, K. L., Stevenson, J. and Cohen, D. J. (1989) The Yale global tic severity scale: initial testing of a clinician-rated scale of tic severity. J. Am. Acad. Child. Adolesc. Psychiatry 28: 566-573.
23. Leckman, J. F., Hardin, M. T., Riddle, M. A., Stevenson, J., Ort, S. I. and Cohen, D. J. (1991) Clonidine treatment of Gilles de la Tourette's syndrome. Arch. Gen. Psychiatry 48: 324-328.
24. Lena, C. and Changeux, J. P. (1993) Allosteric modulations of the nicotinic acetylcholine receptor. Trends Neurosci. 16: 181-186.
25. Levin, E. D., Briggs, S. J., Christopher, N. C. and Rose, J. E. (1992) Persistence of chronic nicotine-induced cognitive facilitation. Behav. Neural. Biol. 58: 152-158.
26. Levin, E. D., Conners, C. K., Sparrow, E., Hinton, S. C., Erhardt, D., Mack, W. H., Rose, J. E. and March, J. (1995) Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology 123: 55-63.
27. McConville, B. J., Fogelson, M. H., Norman, A. B., Klykylo, W. M., Manderscheid, M. A., Parker, K. W. and Sanberg, P. R. (1991) Nicotine potentiation of haloperidol in reducing tic frequency in Tourette's disorder. Am. J. Psychiatry 148: 793-794.
28. McConville, B. J., Sanberg, P. R., Fogelson, M. H., King, J., Cirino, P., Parker, K. W. and Norman, A. B. (1992) The effects of nicotine plus haloperidol compared to nicotine only and placebo only in reducing tic frequency and severity in Tourette's syndrome. Biol. Psychiatry 31: 832-840.
29. Montgomery, S. P., Moss, D. E. and Manderscheid, P. Z. (1985) Tetrahydrocannabinol and levonatradol effects on extrapyramidal motor behaviors. In: Marijuana 84, pp. 295-302, Harvey, D. J. and Paton, W. D. M. (eds.) IRL Press, Oxford.
30. Moss, D. E., Manderscherd, P. Z., Montgomery, S. P., Norman, A. B. and Sanberg, P. R. (1989) Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome. Life Sci. 44: 1521-1525.
31. Newhouse, P. A., Sunderland, T., Thompson, K., Tariot, P. N., Weingartner, H., Mueller, E. R., Cohen, R. M. and Murphy, D. L. (1986) Intravenous nicotine in a patient with Alzheimer's disease. Am. J. Psychiatry 143: 1494-1495.
32. Ochoa, E. L. M., Chattopadhyay, A. and McNamee, M. G. (1989) Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators. Cell Mol. Neurobiol. 9: 141-178.
33. Pauls, D. L., Towbin, K. E., Leckman, J. F., Zahner, G. E. P. and Cohen, D. J. (1986) Gilles de la Tourette syndrome and obsessive compulsive disorder: evidence supporting an etiological relationship. Arch. Gen. Psychiatry 43: 1180-1182.
34. Riddle, M. A., Hardin, M. T., King, R., Scahill, L. and Woolston, J. L. (1990) Flouxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: preliminary clinical experience. J. Am. Acad. Child. Adolesc. Psychiatry 29: 45-48.
35. Robertson, M. M. (1989) The Gilles de la Tourette syndrome: the current status. Br. J. Psychiatry 154: 147-169.
36. Salín-Pascual, R. J., de la Fuente, J. R., Galicia-Polo, L. and Drucker-Colín, R. (1995) Effects of transdermal nicotine on mood and sleep in nonsmoking major depressed patients. Psychopharmacology 121: 476-479.
37. Sanberg, P. R., McConville, B. J., Fogelson, H. M., Manderscheid, P. Z., Parker, K. W., Blythe, M. M., Klykylo, W. M. and Norman, A. B. (1989) Nicotine potentiates the effects of haloperidol in animals and patients with Tourette syndrome. Biomed. & Pharmacother. 43: 19-23.
38. Shapiro, A. K. and Shapiro, E. S. (1988) Treatment of tic disorders with haloperidol. In: Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment (Wiley Series In Child and Adolescent Mental Health), pp. 267-280, Cohen, D. J., Bruun, R. D. and Leckman, J. F. (eds.) John Wiley and Sons, New York.
39. Shapiro, E. S., Shapiro, A. K., Fulop, G., Hubbard, M., Mandeli, J., Nordie, J. and Phillips, R. A. (1989) Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette's syndrome. Arch. Gen. Psychiatry 46: 722-730.
40. Sharp, B. M. and Beyer, S. (1986) Rapid desensitization of the acute stimulatory effects of nicotine on rat plasma adrenocorticotropin and prolactin. J. Pharmacol. Exp. Ther. 238: 486-491.
41. Shytle, R. D., Silver, A. A., Philipp, M. K., McConville, B. J. and Sanberg, P. R. (1996) Transdermal nicotine for Tourette's syndrome. Drug Dev. Res. 38: 290-298.
42. Silver, A. A. and Hagin, R. A. (1990) Gilles de la Tourette's Syndrome. In: Disorders of Learning in Childhood (Wiley Series In Child and Adolescent Mental Health), pp. 469-508, Noshpitz, J. D. (ed.) John Wiley and Sons, New York.
43. Silver, A. A., Shytle, R. D., Philipp, M. K. and Sanberg, P. R. (1995) Transdermal nicotine in Tourette's syndrome. In: The Effects of Nicotine on Biological Systems II, Advances in Pharmacological Sciences, pp. 293-299, Clarke, P. B. S., Quik, M. and Thurau, K. (eds.) Birkhauser Publishers, Boston.
44. Silver, A. A., Shytle, R. D., Philipp, M. K. and Sanberg, P. R. (1996) Long term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome. J. Am. Acad. Child. Adolesc. Psychiatry 35: 1631-1636.
45. Singer, H. S., Butler, I. J., Tune, L. E., Seifert, W. E., Jr. and Coyle, J. T. (1982) Dopaminergic dysfunction in Tourette syndrome. Ann. Neurol. 12: 361-366.
46. Singer, H. S., Gammon, K. and Quaskey, S. (1985-1986) Haloperidol, fluphenazine and clonidine in Tourette syndrome: controversies in treatment. Pediatr. Neurosci. 12: 71-74.
47. Sivilotti, L. and Colquhoun, D. (1995) Acetylcholine receptors: too many channels, too few functions. Science 269: 1681-1682.
48. Tourette Syndrome Classification Study Group (1993) Definitions and classification of tic disorders. Arch. Neurol. 50: 1013-1016.
49. U.S. Department of Health and Human Services (1988) The Health Consequences of Smoking: Nicotine Addiction. A Report of the Surgeon General, DHHS Pub. No. CDC 88-8406. U.S. Government Printing Office, Washington, DC.
50. Wilbert, J. (1991) Does pharmacology corroborate the nicotine therapy and practices of South American schamanism. J. Ethnopharmacol. 32: 179-186.
51. Wonnacott, S., Irons, J., Rapier, C., Thorne, B. and Lunt, G. G. (1989) Presynaptic modulation of transmitter release by nicotinic receptors. Prog. Brain. Res. 79: 157-163.